Skip to main content
CDC Website

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Rifampin

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
Audiences:
Adolescents/Youth/Teens
Adults
Black or African American persons
Asian & Pacific Islanders
At Risk Persons
Parents/Families
Non-U.S.-born persons
General Public
Hispanic or Latino persons
People experiencing homelessness
Minorities
American Indian or Alaska Native persons
Older Adults
Persons with Latent TB
Persons with TB
Author:
Oregon Health Authority, Public Health Division
Publication Language:
Spanish
Subjects:
Counseling
TB
TB Treatment
Tuberculosis (TB) Treatment
Publication Date:
2013
Format:
Information Sheet
1 p: col., table.